Single approach to tackling NCDs, NTDs includes improving governance, strengthening health systems

NewsGuard 100/100 Score

In this "End the Neglect" blog post, Alanna Shaikh, a writer for U.N. Dispatch, follows up on her previous post in which she asserts that "there is a single approach that will help to fight both" non-communicable diseases (NCDs) and neglected tropical diseases (NTDs), writing that in order to tackle both types of diseases "we can improve governance and we can strengthen health systems." She writes, "Whether you are looking at emergency response, stopping an epidemic, or fighting chronic illnesses, you need a government that can create an environment that supports good health and functional health care," and adds "that without a solid health system, you can't defeat any kind of health issues, let alone face the thorny complexity of eliminating [NTDs] or [NCDs]" (10/14).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study shows ritonavir-boosted nirmatrelvir remains effective against new omicron variants in the U.S